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E-mail address: m-jasin@ski.mskcc.org (M. Jasin).DNA double-strand breaks resulting from normal cellular processes including replication and exog-
enous sources such as ionizing radiation pose a serious risk to genome stability, and cells have
evolved different mechanisms for their efﬁcient repair. The two major pathways involved in the
repair of double-strand breaks in eukaryotic cells are non-homologous end joining and homologous
recombination. Numerous factors affect the decision to repair a double-strand break via these path-
ways, and accumulating evidence suggests these major repair pathways both cooperate and com-
pete with each other at double-strand break sites to facilitate efﬁcient repair and promote
genomic integrity.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
DNA damage constantly occurs in cells as a result of both envi-
ronmental and endogenous insults. Double-strand breaks (DSBs),
which may arise during the normal course of DNA replication and
as a result of exposure to DNA damaging agents, are considered
one of the most cytotoxic forms of DNA damage [1]. The ability to
accurately repair these breaks is essential for faithful propagation
of genetic information. Deﬁciencies in DSB repair can lead to muta-
tions and chromosomal rearrangements that ultimately may result
in genomic instability and tumorigenesis. Therefore, cells have
evolved effective mechanisms for the accurate and timely repair
of DSBs in DNA.
Two major pathways are involved in the repair of DSBs in
eukaryotic cells: non-homologous end joining (NHEJ) and homolo-
gous recombination (HR) [2,3]. NHEJ is an efﬁcient pathway that
functions throughout the cell cycle and involves the ligation of
DNA ends with minimal processing at the site of end joining, while
HR, occurring speciﬁcally in late S and G2 phases of the cell cycle,
utilizes an undamaged homologous sequence as a repair template,
preferably the sister chromatid, and is considered a more precise
method for repairing DSBs in DNA. This review focuses on the col-
laboration and competition of the two major pathways of DSB re-
pair in mammalian cells, with an emphasis on factors affecting the
decision to repair breaks via HR or NHEJ.chemical Societies. Published by E2. Mechanisms of homologous recombination
HR is initiatedby resection of DNAends at theDSB site to yield 30-
single-stranded DNA (ssDNA) overhangs which are capable of
invading duplex DNA containing a homologous sequence [4]. Stud-
ies in Saccharomyces cerevisiae suggest that the MRX complex, en-
coded by MRE11, RAD50 and XRS2 (the ortholog of NBS1 in
mammalian cells), together with the Sae2 protein, is required for
the initial end processing step of HR. More extensive processing in-
volves the 50–30 exonuclease Exo1 or the combined helicase/nucle-
ase activities of Sgs1/Dna2 [5,6]. The functional counterpart of
Sae2 in vertebrate cells is CtIP [7]. The protein product of the breast
cancer susceptibility gene BRCA1 interacts with both MRN and CtIP,
and genetic and physical evidence suggests that BRCA1 may be in-
volved in end resection [8–10], although its exact role remains
uncertain. There is, however, data supporting a role for mammalian
counterparts of Exo1 and Sgs1 in end resection: humanEXO1 can re-
sect DNA ends in vitro, and its activity is stimulated by Bloom’s syn-
drome protein (BLM), the Sgs1 ortholog [11]. DNA ends resected by
EXO1andBLMareutilized in subsequent strand exchange reactions.
The 30-single-stranded DNA overhang generated during end
resection is bound by replication protein A (RPA), which is required
for the subsequent recruitment of checkpoint and HR proteins such
as RAD51 [12]. RAD51, a homolog of the bacterial RecA protein, is a
DNA-dependent ATPase that forms nucleoprotein ﬁlaments with
DNA. In mammalian cells, RAD51 is recruited to DSBs by the pro-
tein product of the breast cancer susceptibility gene BRCA2 [13].
BRCA2 is a large (410kD) protein that binds RAD51 through inter-
actions with a series of eight short conserved repeats termed BRClsevier B.V. All rights reserved.
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more BRC repeats stimulate RAD51 nucleoprotein ﬁlament forma-
tion on ssDNA in the presence of ATP [16,17]. Moreover, structural
studies have demonstrated that BRCA2 itself binds to ssDNA [18].
Both BRCA1 and BRCA2 mutant cells are defective for HR
[19,20]. BRCA2 appears to interact with BRCA1 via the BRCA2
‘‘partner” PALB2; mutations in PALB2 that disrupt binding to either
BRCA1 or BRCA2, as well as clinically relevant mutations in BRCA1
which abrogate binding to PALB2, result in decreased levels of HR
[21–24]. Additionally, BRCA2 forms a complex with DSS1, a con-
served 70 amino acid protein required for DNA damage-induced
RAD51 foci formation, and presumably HR, in mammalian cells
[18,25,26]. In yeast, BRCA2 (as well as BRCA1 and PALB2) is not
present; therefore, other proteins such as Rad52 assist in loading
Rad51 onto ssDNA [12].
Once recruited to the DSB, RAD51 catalyzes strand exchange
during which ssDNA invades homologous duplex DNA forming a
displacement loop (D-loop). Recently solved crystal structures of
Escherichia coli RecA-ssDNA and RecA-heteroduplex ﬁlaments have
shed new light on how RAD51 may facilitate strand exchange [27]:
RecA-bound ssDNA is stretched globally but maintains a B-DNA-
like conformation locally in base triplets; this unusual structure fa-
vors Watson–Crick type base pairing during homology sampling
with the complementary strand in a destabilized donor duplex
DNA.
Once formed, the D-loop has multiple fates [12]. In the primary
pathway in mitotic cells, termed synthesis-dependent strand
annealing, the 30 end in the D-loop is extended by repair synthesis,
and then the newly synthesized DNA strand dissociates to anneal
to the other DNA end to complete the reaction. If the second
DNA end is ‘‘captured” by the D-loop, a double Holliday junction
forms that can potentially be resolved by several different proteins,
including in humans GEN1 and SLX1/SLX4 [4,28]. As double Holli-
day junction resolution can occur in different ways, crossover and
non-crossover products are possible. While crossovers play an
important role in facilitating chromosome segregation during mei-
otic recombination [29], crossovers occurring during mitotic
recombination may have serious deleterious effects, including loss
of heterozygosity [3]. Proteins that disrupt D-loops or ‘‘dissolve”
Holliday junctions (such as BLM) suppress mitotic crossovers,
thereby decreasing the risk of genomic instability [30].3. Repair by single-strand annealing
Another repair pathway involving sequence homology, but dis-
tinct from HR, is single-strand annealing (SSA) [31]. SSA can occur
following end resection if sequence repeats exist on both sides of
the DSB. The complementary single strands formed at the repeats
then anneal and ﬂaps formed from the annealing reaction are
trimmed off, resulting in a loss of sequence between the repeats.
Compared to HR, SSA is therefore more mutagenic because it in-
volves loss of genetic information. Proteins identiﬁed to promote
SSA in mammalian cells and yeast include RAD52 (annealing)
and ERCC1 and Rad1/Rad10 (ﬂap endonuclease) [8,32,33].4. Repair by non-homologous end joining
NHEJ proteins were initially identiﬁed through their require-
ment for resistance to ionizing radiation and V(D)J recombination
in the immune system [2]. The ﬁrst protein in this pathway to bind
DNA ends is the Ku70/80 heterodimer (Ku). In mammalian cells, Ku
interacts with the DNA-dependent protein kinase catalytic subunit
(DNA-PKcs) and together they may act to synapse the two DNA
ends to be repaired [34]. DNA ends are joined by the DNA ligase
IV/XRCC4 complex [35]. XRCC4 does not possess any known enzy-matic activity but acts as a scaffold that forms interactions with
both Ku and DNA and both stabilizes and stimulates the ligase
activity of DNA ligase IV [36].
NHEJ can join DNA ends with a number of different structures.
As a result, this pathway makes use of a number of processing
steps that may include cleavage and gap ﬁlling prior to ligation.
The nuclease Artemis is recruited to a DSB site by its interactions
with DNA-PKcs, and the Artemis/DNA-PKcs complex is able to
cleave a variety of damaged DNA overhangs [37]. Cleavage of
DNA ends may result in gaps in the DNA that need to be ﬁlled in
by polymerases involved in NHEJ. Members of the PolX family in-
clude polymerases l and k, which interact with the Ku:DNA com-
plex via BRCT domains [38], although data in yeast suggests that
other polymerase families can substitute [39]. The modiﬁcation
of DNA ends prior to joining by these processing steps can lead
to deletions and insertions accounting for the more error-prone
nature of NHEJ compared to HR.
The pathway thus described is considered to be the ‘‘canonical”
NHEJ pathway. However, almost from their initial characterization,
cell mutants for the canonical NHEJ factors have been recognized
to join DSBs with good efﬁciency in certain contexts, for example,
endonuclease-generated DSBs in plasmid and chromosomal DNA
[40,41] and immune system-generated DSBs in mice [42,43]. NHEJ
in the absence of the canonical factors is termed alternative NHEJ
(alt-NHEJ), but whether this is a distinct pathway is uncertain,
although a number of reports have suggested the involvement of
a number of other factors (see e.g., [44]). Canonical NHEJ and alt-
NHEJ seem to differ by the amount of microhomology at the site
of joining. Small sequence microhomologies may help to align bro-
ken strands of DNA, but whereas microhomology at breakpoint
junctions can occur in canonical NHEJ at frequencies expected by
chance, longer microhomologies are over-represented in junctions
arising from alt-NHEJ [45].5. Regulation of repair pathway choice
DSB repair pathway choice is regulated by several factors,
including the nature of the lesion and cell cycle phase. Pro-
grammed DSBs are channeled into speciﬁc repair pathways, e.g.,
DSBs generated during V(D)J recombination by the RAG proteins
are repaired by NHEJ [46], whereas DSBs generated during meiosis
by the Spo11 protein are repaired by HR [29]. Several factors may
enforce pathway choice for programmed DSBs. For example, Spo11
forms a covalent linkage with DNA and is cleaved off of DNA by the
MRX/Sae2 proteins [47]. Moreover, in mouse Ku has been reported
to be down regulated early in meiotic prophase, which would pre-
sumably lessen NHEJ [48]. Finally, DSBs arising during DNA repli-
cation may typically be one ended, requiring HR for repair, as
NHEJ of two one-ended DSBs would give rise to translocations [49].
More generally, cell cycle phase is a primary determinant in
restricting HR, whereas NHEJ operates throughout the cell cycle
[50]. The restriction in HR to the S/G2 phases of the cell cycle
makes sense from the standpoint that the primary repair template
in mammalian cells is the sister chromatid, which is not present in
G1 cells. By contrast, in yeast diploid cells are able to efﬁciently use
the homolog for DSB repair [51,52]. Why might the homolog be
used efﬁciently in yeast for repair but not in mammalian cells? A
simple explanation may be that the chance for random collision
between homologs is greater in the much smaller yeast nucleus
than it is in the mammalian nucleus [53]. That proximity matters
is supported by efﬁcient interhomolog recombination in Drosoph-
ila, where homologs are actually paired [54].
Cell cycle phase also plays a more active role in regulating HR in
that end resection is promoted by cyclin-dependent protein ki-
nases (CDKs). In yeast, CDK activity is required for efﬁcient end
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of CDK is Sae2, which is phosphorylated at serine 267 [57]. Cells
expressing a non-phosphorylatable Sae2 protein have similar phe-
notypes to a sae2 null mutant, including delayed HR; conversely,
cells expressing the phospho-mimicking sae2-S267E protein un-
dergo some end resection even in the absence of CDK activity,
while demonstrating accelerated HR. Interestingly, the limited
homology between Sae2 and CtIP includes Sae2 Ser267 and the
CtIP equivalent Thr847, and abrogation of phosphorylation at CtIP
Thr847 impairs end resection, as measured by RPA phosphoryla-
tion [58].
CDK also phosphorylates another site on CtIP, Ser327, which has
been reported to promote CtIP/BRCA1 interaction during S/G2
phases [9,59,60]. Furthermore, CDK-dependent phosphorylation
of BRCA2 at Ser3291 interferes with the ability of Rad51 to interact
with BRCA2 C-terminus; interestingly, phosphorylation peaks dur-
ing M phase, suggesting a link between disassembly of Rad51 ﬁla-
ments and mitotic entry [61–63].
6. Collaboration between NHEJ and HR
There is signiﬁcant evidence that HR and NHEJ collaborate to
enhance overall DNA repair and safeguard genomic integrity. Both
HR and NHEJ are essential DNA damage repair pathways in mice, as
single knockouts for multiple components of either pathway die
during embryogenesis (e.g., HR: Rad51, BRCA2, and XRCC2; NHEJ:
DNA ligase IV and XRCC4) [64]. A notable example of the require-
ment for both pathways for genomic integrity is in the developing
brain, where differential effects are seen with loss of either path-
way: apoptosis arises during early proliferative stages from disrup-
tion of HR (likely from unrepaired DNA damage arising during
replication) and during post-mitotic stages from disruption of
NHEJ (where HR would not be possible) [65].
Further evidence of the collaboration between pathways comes
from double mutant analysis of HR and NHEJ components. These
studies suggest that concomitant loss of a protein involved in HR
and a protein involved in NHEJ results in a more severe phenotype
than would be expected from loss of either single pathway, with
signiﬁcant evidence of genomic instability [66,67]. Micewithmuta-
tions in both the HR component Rad54 and the NHEJ protein Ku80,
both of which are viable as single mutants, show decreased sur-
vival, extreme sensitivity to even low doses of ionizing radiation,
and, at the cellular level, increased accumulation of unrepaired
DSBs, as measured by c-H2AX foci, even in the absence of DNA
damage [67]. Similarly, embryonic ﬁbroblasts deﬁcient for both
Rad54 and the DNA ligase IV also exhibit high levels of spontaneous
DNA damage and accumulate a substantial number of chromatid
breaks [66]. Chicken cellsmutated for Rad54 and Ku70 or DNA-PKcs
also show extreme radiosensitivity [68,69]. The substantially in-
creased DNA damage in these double mutant combinations implies
cooperation between HR and NHEJ, even during the same phase of
the cell cycle. One suggestion is that when HR is reduced one-ended
DSBs arising during replication convert into two-ended DSBs by
fork convergence, providing a substrate for NHEJ [67].
7. Competition between HR, SSA, and NHEJ
While collaboration between HR and NHEJ is necessary for the
maintenance of genomic integrity, competition between DSB re-
pair pathways is also evident. This competition is most apparent
in mutants that affect either end resection (Fig. 1, 1 and 2) or the
ability of a resected end to be channeled into HR (Fig. 1, 3). Thus,
NHEJ mutants that have enhanced end resection (e.g., Ku) have in-
creased HR and SSA, while mutants with decreased end resection
(e.g., Sae2/CtIP) have increased NHEJ.7.1. NHEJ mutants with enhanced end resection
An enhanced rate of end resection has been demonstrated in a
yeast Ku mutant using direct molecular analysis [70]; since Ku
binds DNA ends, it presumably physically blocks access of the
end resection machinery. More recently, the homolog of DNA li-
gase IV/XRCC4 in yeast, Dnl4-Lif1, has also been shown to have
an inhibitory effect on end resection, possibly by stabilizing Ku at
DNA ends, although the effect is somewhat less pronounced than
with Ku [71].
Consistent with an increase in the end resected intermediate,
mutation of Ku or DNA ligase IV/XRCC4 in mammalian cells leads
to increased HR, with mutation of Ku showing a more profound
effect [49]. Loss of DNA-PKcs, which does not have an ortholog in
yeast, also increases HR [49,72], although as yet a role for DNA-
PKcs in inhibiting end resection has not been shown. As with
mammalian cells, chicken cells mutated for Ku or DNA-PKcs also
show increased HR compared with wild-type cells [69]. Notably,
the increase of HR in NHEJ mutants occurs whether the DSB is
introduced by I-SceI endonuclease, which generates a 30 over-
hang, or the RAG recombinase, which generates a hairpin capped
end [49,73]. SSA, which has an end-resected intermediate like
HR, is also increased with loss of Ku or DNA ligase IV/XRCC4
[8,74].
The ﬁnding that Ku can suppress repair through other pathways
has implications for other NHEJ mutants. Ku and DNA ligase IV/
XRCC4 mutants share many phenotypes; however, DNA ligase IV/
XRCC4 mice are not viable whereas Ku mutant mice are viable,
although they have reduced vigor [67,75]. Intriguingly, the embry-
onic lethality of DNA ligase IV-deﬁcient mice can be rescued by
deletion of Ku, suggesting that Ku blocks access to other repair
pathways even in other NHEJ mutants [76]. (But see also discussion
in [76].) Moreover, in chicken cells, Ku mutation actually leads to
increased resistance to ionizing radiation during late S/G2 both in
otherwise wild-type cells as well as in DNA-PKcs mutant cells
[69]; this has been interpreted as Ku interference of HR during
these phases of the cell cycle.
In addition to canonical NHEJ factors, the DNA damage re-
sponse factor 53BP1 has been suggested to play an important role
in NHEJ [77,78], and reports have linked 53BP1 disruption to in-
creased HR [77,79]. Notably, 53BP1 loss restores viability to
BRCA1 null cells [80] and BRCA1 mutant mice [81]. Mechanistic
studies have provided evidence that 53BP1 loss restores HR levels
in BRCA1-deﬁcient cells [80,82], possibly by unleashing end
resection at DSBs from inhibition by 53BP1 [82]. Interestingly,
53BP1 loss does not rescue the viability of BRCA2 null cells
[82]; these results are consistent with genetic studies that place
BRCA1 upstream of BRCA2 in HR, such that BRCA2 mutants are
deﬁcient at a step after end resection (see below). These studies
point to the important consequences of the interplay of HR and
NHEJ, which may have implications for human tumorigenesis
[80,83].
7.2. End resection mutants
In yeast, resected DNA ends appear to be less prone to repair via
NHEJ [84], consistent with the observation that HR mutants like
BRCA2, which have resected intermediates, do not show an appar-
ent increase in NHEJ [8]. Thus, interference of end resection would
be predicted to increase NHEJ levels. Consistent with this, both
sae2 null and sae2-S267A mutants show increased frequencies of
NHEJ in addition to delayed HR [57]. Vertebrate cells deﬁcient for
CtIP have also been reported to show increased NHEJ [44,60],
although the role of CDK phosphorylation in modulating its activity
is as yet unresolved [85].
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Fig. 1. Competition between double-strand break repair pathways. DNA double-strand breaks (DSBs) are repaired by two distinct pathways, homologous recombination (HR)
and non-homologous end joining (NHEJ). HR is initiated by 50 to 30 end resection, forming a 30 single-stranded tail onto which Rad51 assembles. The Rad51 nucleoprotein
ﬁlament allows single-strand DNA invasion into a homologous duplex, typically the sister chromatid, to initiate repair synthesis. The newly synthesized strand is then
displaced to anneal to the other DNA end (not shown) to complete the HR reaction. When a DSB and subsequent end resection occurs at sequence repeats (green lines), an
alternative pathway, single-strand annealing (SSA), can take place. The complementary single strands at the repeats can anneal, giving rise to a copy number variant, in this
case a product with a single copy of the repeat and a deletion of the intervening sequence. NHEJ involves the joining of DNA ends with no or little homology (microhomology).
In this pathway, the Ku heterodimer binds to DNA ends, protecting them from end resection. A number of processing factors are subsequently recruited (not shown), which
allows a variety of end structures to be joined. Mutational analysis has demonstrated that factors involved in HR and NHEJ likely directly ‘‘compete” at steps indicated by the
numbers: (1) loss of canonical NHEJ factors (Ku, DNA ligase IV/XRCC4) leads to increased end resection and hence HR and SSA. (2) End resection mutants (e.g., Sae2) have
increased NHEJ. (3) Disruption of Rad51 ﬁlament formation allows DNA ends to be channeled into SSA.
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Once a resected DNA end has been formed, it becomes a sub-
strate for Rad51 ﬁlament formation. Several HR mutants have
been identiﬁed in which Rad51 ﬁlament formation is disrupted,
including BRCA2, RAD54, RAD51 paralogs, and ATP binding mu-
tants of RAD51 itself, and in each of these mutants, SSA is in-
creased in model substrates [8,86–88]. For example, with the
RAD51-K133A mutant, the ratio of HR to SSA is shifted 93-fold
(22-fold decrease in HR and 4.2-fold increase in SSA) [8]. In endog-
enous genomic sequences, homologous repeats are not as likely to
be present close by and with identical or nearly identical sequence
(see [89,90] for effects of repeat heterology and distance on SSA).
Nonetheless, the tremendous shift towards this mutagenic path-
way likely contributes to the mutation load found in these various
HR mutants.
8. HR vs. NHEJ pathway choice and the Fanconi anemia pathway
More recent analysis has implicated Ku in regulating pathway
choice in the repair of other DNA lesions, in particular those caused
by crosslinking agents like cisplatin or mitomycin C. Cells derived
from Fanconi anemia patients are extremely sensitive to crosslink-
ing agents due to mutations in any number of FANC genes [91].
Like BRCA1 mutant cells, FANC mutant cells show small defects
in both HR and SSA in the repair of a DSB [92], as well as increased
radial chromosomes, apparently from aberrant NHEJ.
In chicken cells, loss of Ku in FANCC mutant cells greatly re-
lieves their cisplatin sensitivity, possibly because HR is increased
in the Ku/FANCC cells compared with FANCC single mutant cells
[93]. A separate study found that Ku mutation also relieves the
sensitivity of human patient derived cell lines (FANCC or FANCD2
mutant) to mitomycin C [94]. These ﬁndings have potentially pro-
found implications for possible therapies for Fanconi anemia
patients.Conﬂicting results were obtained in these two studieswith other
NHEJ mutants. In chicken cells, neither DNA ligase IV nor DNA-PKcs
deﬁciency relieves cisplatin sensitivity of FANCC mutant cells; in
fact, DNA ligase IV deﬁciency further sensitizes the FANCC cells to
cisplatin, consistent with additive repair defects rather than a sup-
pression of repair defects found with Ku deﬁciency [93]. By con-
trast, in patient derived cells, loss of DNA ligase IV or DNA-PKcs,
like Ku, relieves the sensitivity of FANC mutant cells to mitomycin
C, and in worms, loss of DNA ligase IV relieves the sensitivity of
FANCD2mutants to cisplatin [94]. What accounts for the difference
between the two reports is uncertain, e.g., whether the interplay
between repair pathways differs in some respect between humans
and worms compared with chickens. However, it is notable that in
DSB repair in mouse cells, all three canonical NHEJ factors suppress
HR, but Ku has the most profound suppression [49], especially for
DSBs induced by the RAG recombinase [73].
9. Summary
DNA damage is constantly occurring in eukaryotic cells, pos-
ing an ongoing threat to genomic stability. Consequently, eukary-
otic cells have evolved multiple pathways for the efﬁcient repair
of DNA damage like DSBs. The coordinated actions of compo-
nents of different repair pathways at DSBs that ultimately navi-
gate repair pathway choice play a critical role in the ability of
cells to repair DNA lesions in a timely and accurate manner.
These safeguards ensure proper development while preventing
tumorigenesis.
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